1 - 25 of 32 results for author:"Ponten F." in Literature citations
Results Customize
› Repeat search in UniProtKB (17)
| Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFbeta2 in vascular abnormalization. Dieterich L.C., Mellberg S., Langenkamp E., Zhang L., Zieba A., Salomaki H., Teichert M., Huang H., Edqvist P.H., Kraus T. et al. J. Pathol. 228:378-390(2012) · Mapped (12) |
| CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression. Sillars-Hardebol A.H., Carvalho B., Belien J.A., de Wit M., Delis-van Diemen P.M., Tijssen M., van de Wiel M.A., Ponten F., Meijer G.A., Fijneman R.J. Cell Oncol (Dordr) 35:293-300(2012) · Mapped (1) |
| Novel pancreatic beta cell-specific proteins: antibody-based proteomics for identification of new biomarker candidates. Lindskog C., Korsgren O., Ponten F., Eriksson J.W., Johansson L., Danielsson A. J Proteomics 75:2611-2620(2012) · Mapped (9) |
| CD99 is a novel prognostic stromal marker in non-small cell lung cancer. Edlund K., Lindskog C., Saito A., Berglund A., Ponten F., Goransson-Kultima H., Isaksson A., Jirstrom K., Planck M., Johansson L. et al. Int. J. Cancer 131:2264-2273(2012) · Mapped (3) |
| Paladin (X99384) is expressed in the vasculature and shifts from endothelial to vascular smooth muscle cells during mouse development. Wallgard E., Nitzsche A., Larsson J., Guo X., Dieterich L.C., Dimberg A., Olofsson T., Ponten F.C., Makinen T., Kalen M. et al. |
| TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression. Sillars-Hardebol A.H., Carvalho B., Tijssen M., Belien J.A., de Wit M., Delis-van Diemen P.M., Ponten F., van de Wiel M.A., Fijneman R.J., Meijer G.A. Gut 61:1568-1575(2012) · Mapped (14) |
| Antibody-based protein profiling of the human chromosome 21. Uhlen M., Oksvold P., Algenas C., Hamsten C., Fagerberg L., Klevebring D., Lundberg E., Odeberg J., Ponten F., Kondo T. et al. Mol. Cell. Proteomics 11:0-0(2012) · UniProtKB (5) |
| BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain. Sillars-Hardebol A.H., Carvalho B., Belien J.A., de Wit M., Delis-van Diemen P.M., Tijssen M., van de Wiel M.A., Ponten F., Fijneman R.J., Meijer G.A. J. Pathol. 226:442-450(2012) · Mapped (2) |
| Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma. Gremel G., Ryan D., Rafferty M., Lanigan F., Hegarty S., Lavelle M., Murphy I., Unwin L., Joyce C., Faller W. et al. Br. J. Cancer 105:565-574(2011) · Mapped (1) |
| SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Magnusson K., de Wit M., Brennan D.J., Johnson L.B., McGee S.F., Lundberg E., Naicker K., Klinger R., Kampf C., Asplund A. et al. Am. J. Surg. Pathol. 35:937-948(2011) · Mapped (6) |
| Sun-induced nonsynonymous p53 mutations are extensively accumulated and tolerated in normal appearing human skin. Stahl P.L., Stranneheim H., Asplund A., Berglund L., Ponten F., Lundeberg J. J. Invest. Dermatol. 131:504-508(2011) · Mapped (32) |
| SOX10 expression in superficial spreading and nodular malignant melanomas. Agnarsdottir M., Sooman L., Bolander A., Stromberg S., Rexhepaj E., Bergqvist M., Ponten F., Gallagher W., Lennartsson J., Ekman S. et al. Melanoma Res. 20:468-478(2010) · Mapped (5) |
| Topoisomerase I amplification in melanoma is associated with more advanced tumours and poor prognosis. Ryan D., Rafferty M., Hegarty S., O'Leary P., Faller W., Gremel G., Bergqvist M., Agnarsdottir M., Stromberg S., Kampf C. et al. Pigment Cell Melanoma Res 23:542-553(2010) · Mapped (5) |
| Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy. Holgersson G., Ekman S., Reizenstein J., Bergqvist M., Ponten F., Uhlen M., Magnusson K., Jonnalagadda P., Asplund A., Stromberg S. et al. Cancer Genomics Proteomics 7:1-7(2010) · Mapped (58) |
| ZBED6, a novel transcription factor derived from a domesticated DNA transposon regulates IGF2 expression and muscle growth. Markljung E., Jiang L., Jaffe J.D., Mikkelsen T.S., Wallerman O., Larhammar M., Zhang X., Wang L., Saenz-Vash V., Gnirke A. et al. PLoS Biol. 7:E1000256-E1000256(2009) · UniProtKB (2) · Mapped (1) |
| The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer. Ghanipour A., Jirstrom K., Ponten F., Glimelius B., Pahlman L., Birgisson H. Cancer Epidemiol. Biomarkers Prev. 18:2949-2956(2009) · Mapped (3) |
| Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma. Stromberg S., Agnarsdottir M., Magnusson K., Rexhepaj E., Bolander A., Lundberg E., Asplund A., Ryan D., Rafferty M., Gallagher W.M. et al. J. Proteome Res. 8:1639-1646(2009) · Mapped (3) |
| Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Paulsson J., Sjoblom T., Micke P., Ponten F., Landberg G., Heldin C.H., Bergh J., Brennan D.J., Jirstrom K., Ostman A. Am. J. Pathol. 175:334-341(2009) · Mapped (6) |
| High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. Gaber A., Johansson M., Stenman U.H., Hotakainen K., Ponten F., Glimelius B., Bjartell A., Jirstrom K., Birgisson H. Br. J. Cancer 100:1540-1548(2009) · Mapped (1) |
| The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas. Bolander A., Agnarsdottir M., Stromberg S., Ponten F., Hesselius P., Uhlen M., Bergqvist M. Cancer Genomics Proteomics 5:293-300(2008) · Mapped (6) |
| Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Alimohammadi M., Dubois N., Skoldberg F., Hallgren A., Tardivel I., Hedstrand H., Haavik J., Husebye E.S., Gustafsson J., Rorsman F. et al. Proc. Natl. Acad. Sci. U.S.A. 106:4396-4401(2009) · Mapped (1) |
| DLG3/SAP102 protein expression in malformations of cortical development: a study of human epileptic cortex by tissue microarray. Qu M., Aronica E., Boer K., Fallmar D., Kumlien E., Nister M., Wester K., Ponten F., Smits A. Epilepsy Res. 84:33-41(2009) · Mapped (3) |
| Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma. Bolander A., Agnarsdottir M., Wagenius G., Stromberg S., Ponten F., Ekman S., Brattstrom D., Larsson A., Einarsson R., Ullenhag G. et al. Melanoma Res. 18:412-419(2008) · Mapped (5) |
| A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse. Rosengren Pielberg G., Golovko A., Sundstrom E., Curik I., Lennartsson J., Seltenhammer M.H., Druml T., Binns M., Fitzsimmons C., Lindgren G. et al. Nat. Genet. 40:1004-1009(2008) · UniProtKB (5) |
| Toward a confocal subcellular atlas of the human proteome. Barbe L., Lundberg E., Oksvold P., Stenius A., Lewin E., Bjorling E., Asplund A., Ponten F., Brismar H., Uhlen M. et al. Mol. Cell Proteomics 7:499-508(2008) |